Anand Varadan - Net Worth and Insider Trading

Anand Varadan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Anand Varadan owns 3 companies in total, including Chiasma Inc (CHMA) , Karyopharm Therapeutics Inc (KPTI) , and Pulmatrix Inc (PULM) .

Click here to see the complete history of Anand Varadan’s form 4 insider trades.

Insider Ownership Summary of Anand Varadan

Ticker	Comapny	Transaction Date	Type of Owner
CHMA	Chiasma Inc	2020-04-22	EVP & Chief Commerical Officer
KPTI	Karyopharm Therapeutics Inc	2018-06-22	EVP & Chief Commercial Officer
PULM	Pulmatrix Inc	2021-07-26	director

Anand Varadan Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Anand Varadan Ownership Network

Ownership Network List of Anand Varadan

No Data

Ownership Network Relation of Anand Varadan

Anand Varadan Owned Company Details

What does Chiasma Inc do?

Who are the key executives at Chiasma Inc?

Anand Varadan is the EVP & Chief Commerical Officer of Chiasma Inc. Other key executives at Chiasma Inc include director & Chief Executive Officer Raj Kannan , President Mark J. Fitzpatrick , and VP & Fin & Admin & PAO Drew Enamait .

Chiasma Inc (CHMA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Chiasma Inc (CHMA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Chiasma Inc (CHMA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Chiasma Inc (CHMA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Chiasma Inc Insider Transactions

No Available Data

What does Karyopharm Therapeutics Inc do?

Who are the key executives at Karyopharm Therapeutics Inc?

Anand Varadan is the EVP & Chief Commercial Officer of Karyopharm Therapeutics Inc. Other key executives at Karyopharm Therapeutics Inc include EVP & Chief Medical Officer Reshma Rangwala , director & President and CEO Richard A. Paulson , and EVP & CFO & Treasurer Michael Mason .

Karyopharm Therapeutics Inc (KPTI) Insider Trades Summary

Over the past 18 months, Anand Varadan made no insider transaction in Karyopharm Therapeutics Inc (KPTI). Other recent insider transactions involving Karyopharm Therapeutics Inc (KPTI) include a net sale of 199,037 shares made by Richard A. Paulson , a net sale of 66,291 shares made by Michael Mason , and a net sale of 47,442 shares made by Sohanya Roshan Cheng .

In summary, during the past 3 months, insiders sold 255,827 shares of Karyopharm Therapeutics Inc (KPTI) in total and bought 0 shares, with a net sale of 255,827 shares. During the past 18 months, 423,673 shares of Karyopharm Therapeutics Inc (KPTI) were sold and 41,140 shares were bought by its insiders, resulting in a net sale of 382,533 shares.

Karyopharm Therapeutics Inc (KPTI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Karyopharm Therapeutics Inc Insider Transactions

No Available Data

What does Pulmatrix Inc do?

Who are the key executives at Pulmatrix Inc?

Anand Varadan is the director of Pulmatrix Inc. Other key executives at Pulmatrix Inc include Interim CFO Peter Ludlum , Chief Medical Officer Margaret Wasilewski , and Vice President & Finance Michelle Siegert .

Pulmatrix Inc (PULM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Pulmatrix Inc (PULM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pulmatrix Inc (PULM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Pulmatrix Inc (PULM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Pulmatrix Inc Insider Transactions

No Available Data

Anand Varadan Mailing Address

Above is the net worth, insider trading, and ownership report for Anand Varadan. You might contact Anand Varadan via mailing address: C/o Chiasma, Inc., 60 Wells Avenue, Newton Ma 02459.

Discussions on Anand Varadan

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.